ENDPOINTS

Exclusive: Lithuanian biotech Atrandi Biosciences raises $25M Series A

A biotech based in Vilnius, Lithuania has won the backing of Lux Capital as the startup plots a US expansion in 2025. Lux led a recently-closed $25 million Series A round for Atrandi Biosciences, Endpoints ...

Feb 18, 2025 - 13:03
 0
Exclusive: Lithuanian biotech Atrandi Biosciences raises $25M Series A
A biotech based in Vilnius, Lithuania has won the backing of Lux Capital as the startup plots a US expansion in 2025. Lux led a recently-closed $25 million Series A round for Atrandi Biosciences, Endpoints ...
Read More

Tags:

Previous Article

These 3 PC transfer apps would normally be $129, but now they’re only $35

Next Article

Exclusive: AI biotech Atomwise hires new CEO, raises $45M Series C

Related Posts

FDA approves Ono’s rare joint tumor drug, setting up battle with Daiichi

FDA approves Ono’s rare joint tumor drug, setting up ba...

Feb 18, 2025  0

Ascletis’ obesity pill looks similar to Roche’s drug, early data suggest

Ascletis’ obesity pill looks similar to Roche’s drug, e...

Feb 19, 2025  0

Vertex operations chief Stuart Arbuckle to retire

Vertex operations chief Stuart Arbuckle to retire

Feb 11, 2025  0